Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

I RheumPAC, Do You?

Jim Engelbrecht, MD  |  Issue: September 2009  |  September 1, 2009

The issue is whether you—each member of the ACR and the ARHP—will take a stand for rheumatology issues today. Visit www.rheumatology.org/RheumPAC for more information.

Dr. Engelbrecht is a rheumatologist in the Arthritis and Rheumatic Disease Center at the Black Hills Orthopedic and Spine Center in Rapid City, S.D., and a RheumPAC committee member.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Illinois Practice First for 100% RheumPAC Participation

Congratulations to the Illinois Bone and Joint Institute in Chicago for 100% RheumPAC participation in 2009!

The eight doctors in this practice made a generous contribution to RheumPAC, the ACR’s political action committee. The practice decided as a whole to donate because of their belief that the ACR needs to become more proactive in the political arena. According to Gerry Eisenberg, MD, a rheumatologist at the institute, “We realize that RheumPAC will increase the presence of rheumatology on Capitol Hill and want to ensure that the ACR is active in the healthcare debate.” RheumPAC assists the ACR in its advocacy efforts by providing more opportunities to meet with members of Congress and educate them on rheumatology-related issues. Supporting candidates fosters relationships and ensures the ACR is a contributor to important healthcare policy discussions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
Physicians from the Illinois Bone and Joint Institute in Chicago. Back row, left to right: John Skosey, Gerry Eisenberg, Al Bello, Pat Schuette. Front row, left to right: Amanda Meyers, Erin Arnold, Mary Moran, Bill Arnold.
Physicians from the Illinois Bone and Joint Institute in Chicago. Back row, left to right: John Skosey, Gerry Eisenberg, Al Bello, Pat Schuette. Front row, left to right: Amanda Meyers, Erin Arnold, Mary Moran, Bill Arnold.

If you are interested in learning more about RheumPAC, contact Katie Jones at (404) 633-3777 or [email protected].

Make a Difference—Visit the ACR’s Advocacy Booth

Stop by the ACR’s Advocacy Booth during the 2009 ACR/ARHP Annual Scientific Meeting to find out how your advocacy efforts can make a difference in the field of rheumatology. Healthcare reform is moving quickly, and the ACR is working hard to ensure that Congress creates positive and effective healthcare reform.

Find out what you can do to help educate your elected officials on the importance of these issues and about other issues that impact you and your patients.  The Advocacy Booth will have talking points on all ACR legislative priorities, up-to-date information on healthcare reform, and instructions on how to contact your members of Congress. You also can receive information on the ACR’s political action committee, RheumPAC. Stop by and find out what you can do to further rheumatology issues on Capitol Hill.

The Whos and Whats of RheumPAC

What issues does RheumPAC focus on?

RheumPAC focuses on the ACR’s top public policy priorities, which include:

  • Healthcare reform;
  • A permanent fix to the sustainable growth rate;
  • Passage of the Arthritis Prevention Control and Cure Act (H.R. 1210/S. 984);
  • Tier IV drug pricing;
  • Passage of the Medicare Fraction Prevention and Osteoporosis Testing Act (H.R. 1894/S. 769); and
  • Increased funding for arthritis research.

Who receives RheumPAC funds?

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:Advocates for ArthritisAdvocating with YouCongressLegislationPoliticsRheumPAC

Related Articles

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    RheumPAC: Answers to FAQs

    September 17, 2017

    What is RheumPAC? RheumPAC is the ACR’s nonpartisan political action committee (PAC) that works to elect and support pro-rheumatology candidates. It is the only PAC dedicated to the interests of the rheumatology profession. RheumPAC was created 10 years ago with the mission of educating, electing and supporting federal lawmakers who understand and can positively address…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences